Evidence map›Paper›PMID 42000903›Full record

ArticleScientific reports2026

High-coercivity CoCr

Abbas Bachacheri, Hossein Nikmanesh, Fatemeh Doryani

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Abbas BachacheriDepartment of Physics, Persian Gulf University, Bushehr, 75169, Iran.
Hossein NikmaneshDepartment of Physics, Persian Gulf University, Bushehr, 75169, Iran. h.nikmanesh@yahoo.com.ORCID http://orcid.org/0000-0001-5515-5702
Fatemeh DoryaniDepartment of Biological Science and Technology, Persian Gulf University, Bushehr, 75169, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report that a high coercivity of CoCr ferrite was achieved via hydrothermal synthesis at low annealing temperatures. In particular, CoCr0.6Fe1.4O4 exhibits a coercivity of 6.841 kOe at an annealing temperature of 150 °C. CoCr0.6Fe1.4O4 nanoparticles were synthesized using a hydrothermal method followed by annealing at 150 °C, 175 °C, 200 °C, and 225 °C to tune their structural and magnetic properties. Vibrating sample magnetometer (VSM) measurements showed that saturation magnetization (Ms=6.43–22.76 emu/g) and remanence (Mr=4.18–15.69 emu/g) increased systematically with grain growth, while the maximum coercivity was obtained at 150 °C due to defect and strain. First-order reversal curve (FORC) analysis revealed multiple interaction mechanisms among nanoparticles, with both positive and negative interaction fields. Also, it shows the coexistence of magnetically soft and hard domains. The Reversal anisotropy parameter, derived from δk/δH as a function of -Hr, exhibited distinct peaks corresponding to hard and soft magnetic phases, confirming anisotropy evolution and consistent trends with hysteresis-derived anisotropy constants. X-ray diffraction (XRD) patterns confirmed a single-phase spinel structure while photoluminescence (PL) spectra results reflecting reduced defect density and recombination. The low PL intensity of the 150 °C sample implies suppressed electron–hole recombination and enhanced photocatalytic efficiency. These results demonstrate that CoCr0.6Fe1.4O4 nanoparticles, with their tunable magnetic and optical responses, are suitable for multifunctional applications such as magnetically separable photocatalysts, magnetic data storage.

Indexed as

AnisotropyAnnealing temperatureCation distributionChromium cobalt ferriteFirst-order reversal curveHigh-coercivityMagnetic properties

Identifiers

PMID42000903
PMCPMC13254304

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.